Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Pharma
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
The FDA broadened the use of BMS' CAR-T therapy Breyanzi to another type of blood cancer, where it'll again compete with Gilead and Novartis drugs.
Angus Liu
May 16, 2024 10:56am
Galapagos bolsters decentralized CAR-T manufacturing
May 15, 2024 5:33pm
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am
Kincell takes on Imugene's North Carolina plant, team for $6M
Apr 16, 2024 3:01pm
J&J, Legend's Carvykti quickly leaps ahead of BMS' rival CAR-T
Apr 8, 2024 8:30am
BMS' Abecma wins earlier myeloma nod with updated boxed warning
Apr 5, 2024 11:46am